Insider Transactions in Q1 2021 at Genocea Biosciences, Inc. (GNCA)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2021
|
Thomas Andrew Davis CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
31,250
+50.0%
|
-
|
|
Mar 15
2021
|
Girish N Aakalu CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
31,250
+50.0%
|
-
|
|
Mar 15
2021
|
Jessica Baker Flechtner Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,750
+50.0%
|
-
|
|
Mar 15
2021
|
William D Clark President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+50.0%
|
-
|
|
Mar 15
2021
|
Diantha Duvall CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+50.0%
|
-
|
|
Feb 17
2021
|
William D Clark President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
36,498
+25.63%
|
$72,996
$2.19 P/Share
|